Navidea Biopharmaceuticals, Inc. (NAVBQ)
0.0001
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Navidea Biopharmaceuticals Net Income (Quarterly)
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -2.255M |
| June 30, 2023 | -1.393M |
| March 31, 2023 | -1.476M |
| December 31, 2022 | -3.483M |
| September 30, 2022 | -5.708M |
| June 30, 2022 | -3.000M |
| March 31, 2022 | -2.987M |
| December 31, 2021 | -3.652M |
| September 30, 2021 | -2.438M |
| June 30, 2021 | -2.674M |
| March 31, 2021 | -2.967M |
| December 31, 2020 | -2.823M |
| September 30, 2020 | -2.899M |
| June 30, 2020 | -2.326M |
| March 31, 2020 | -2.674M |
| December 31, 2019 | -2.772M |
| September 30, 2019 | -3.074M |
| June 30, 2019 | -2.674M |
| March 31, 2019 | -2.426M |
| December 31, 2018 | -3.176M |
| September 30, 2018 | -3.822M |
| June 30, 2018 | -2.435M |
| March 31, 2018 | -6.738M |
| December 31, 2017 | -6.17M |
| September 30, 2017 | -1.541M |
| Date | Value |
|---|---|
| June 30, 2017 | -3.152M |
| March 31, 2017 | -2.865M |
| December 31, 2016 | -2.118M |
| September 30, 2016 | -1.761M |
| June 30, 2016 | -0.8165M |
| March 31, 2016 | -2.682M |
| December 31, 2015 | -3.269M |
| September 30, 2015 | -8.071M |
| June 30, 2015 | -9.691M |
| March 31, 2015 | -7.291M |
| December 31, 2014 | -6.865M |
| September 30, 2014 | -6.899M |
| June 30, 2014 | -10.22M |
| March 31, 2014 | -11.74M |
| December 31, 2013 | -13.75M |
| September 30, 2013 | -11.31M |
| June 30, 2013 | -10.30M |
| March 31, 2013 | -7.341M |
| December 31, 2012 | -7.235M |
| September 30, 2012 | -9.099M |
| June 30, 2012 | -5.835M |
| March 31, 2012 | -6.989M |
| December 31, 2011 | -7.562M |
| September 30, 2011 | -0.0559M |
| June 30, 2011 | -2.189M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Windtree Therapeutics, Inc. | -28.08M |
| Biostax Corp. | -- |
| GeneLink, Inc. | -- |
| NovAccess Global, Inc. | -- |
| Trevena, Inc. | -- |